Oxycodone (Oxycodone Amneal) 5 mg and 10 mg tablets: Supply issue

Last Updated: 21 March 2025

Supply issue Active

Due to shipping delays, there is a supply issue affecting the 5 mg and 10 mg immediate release oxycodone tablets.

21 March 2025 | Update

Stock of the 10 mg tablets is out at supplier level but some stock remains in the supply chain. Resupply of the 10 mg is expected early April.

Resupply of the 5 mg is expected in late March.

There can be up to one to two weeks before stock can reach pharmacies around the motu.

Affected product

Due to shipping delays, there is a supply issue affecting oxycodone hydrochloride

Presentation: Tab immediate-release 5 mg
- Brand: Oxycodone Amneal
- Pharmacode: 2681919 and 2696053
- Subsidy: $13.77
- Measure / Qty: per 100
Presentation: Tab immediate-release 10 mg
- Brand: Oxycodone Amneal
- Pharmacode: 2681927 and 2696061
- Subsidy: $18.77
- Measure / Qty: per 100

Schedule listing for oxycodone(external link)

Unaffected products

Currently, there are no concerns for the 20 mg tablets, oral liquid, or the controlled-release capsules.

Alternative product

The oral liquid (1 mg / ml) is available. Rule 3.4.2 applies for funding, however a new prescription may be needed to meet requirements of the Misuse of Drugs Regulations.

Prescribers may also want to consider prescribing an alternative analgesic.

We acknowledge that this will cause create disruption for those affected. We have developed a flyer to support conversations with people affected by this supply issue.

Flyer: Oxycodone IR 5 mg supply issue (Mar 25) [PDF 56 KB]

Expected resupply

The next shipment of 5 mg tablets is due by late March 2025.

The next shipment of 10 mg tablets is due early April 2025.

It will take another 1 to 2 weeks for product to reach pharmacies around the motu.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.